Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/131376
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Can CMR elucidate the cardiovascular benefit of SGLT2 inhibitors? |
Author: | Nicholls, S.J. Nerlekar, N. |
Citation: | JACC: Cardiovascular Imaging, 2021; 14(6):1174-1176 |
Publisher: | Elsevier |
Issue Date: | 2021 |
ISSN: | 1936-878X 1876-7591 |
Statement of Responsibility: | Stephen J. Nicholls, Nitesh Nerlekar |
Abstract: | Abstract not available |
Keywords: | CMR SGLT2 inhibitors cardiovascular clinical trials interstitial |
Rights: | © 2021 by The American College of Cardiology Foundation published by Elsevier |
DOI: | 10.1016/j.jcmg.2020.11.003 |
Published version: | http://dx.doi.org/10.1016/j.jcmg.2020.11.003 |
Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.